Literature DB >> 24867125

Decision making after BRCA genetic testing. Down the road of transition.

Laurie M Connors1, Nicoleta Voian2, Yi Shi3, Robin M Lally4, Stephen Edge5.   

Abstract

The purpose of this study was to evaluate women who have completed hereditary cancer risk assessment and BRCA genetic testing to determine if they considered themselves prepared to proceed with decision making regarding cancer screening and prevention options. Levels of decisional conflict were explored, as was their preference for information delivery. The prospective, descriptive survey was conducted at a breast and clinical genetics clinic at a comprehensive cancer center in the northeastern United States. Twenty-seven female participants completed the Preparation for Decision Making scale, Decisional Conflict Scale, and a demographic questionnaire. Scores were consistent with high levels of preparation for decision making and low decisional conflict. The face-to-face approach was the preferred method for information delivery. Subgroup analysis demonstrated a difference in the measured objectives based on cancer status but not based on BRCA status. The current information delivery approach is meeting the decision-making needs of women considered to be at increased risk for hereditary breast and ovarian cancer.

Entities:  

Keywords:  breast cancer; cancer program development/evaluation; communication; genetics/genomics; gynecologic malignancies

Mesh:

Year:  2014        PMID: 24867125     DOI: 10.1188/14.CJON.E58-E63

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  10 in total

1.  Women with Family History of Breast Cancer: How Much Are They Aware of Their Risk?

Authors:  Memnun Seven; Gülcan Bağcivan; Aygul Akyuz; Ferdağ Bölükbaş
Journal:  J Cancer Educ       Date:  2018-08       Impact factor: 2.037

2.  Should pretest genetic counselling be required for patients pursuing genomic sequencing? Results from a survey of participants in a large genomic implementation study.

Authors:  Joel E Pacyna; Carmen Radecki Breitkopf; Sarah M Jenkins; Erica J Sutton; Caroline Horrow; Iftikhar J Kullo; Richard R Sharp
Journal:  J Med Genet       Date:  2018-12-22       Impact factor: 6.318

3.  Involvement and Influence of Healthcare Providers, Family Members, and Other Mutation Carriers in the Cancer Risk Management Decision-Making Process of BRCA1 and BRCA2 Mutation Carriers.

Authors:  Athena Puski; Shelly Hovick; Leigha Senter; Amanda Ewart Toland
Journal:  J Genet Couns       Date:  2018-03-29       Impact factor: 2.537

4.  An in-depth exploration of the post-test informational needs of BRCA1 and BRCA2 pathogenic variant carriers in Asia.

Authors:  Jeanette Yuen; Si Ming Fung; Chin Leong Sia; Mallika Venkatramani; Tarryn Shaw; Eliza Courtney; Shao-Tzu Li; Jianbang Chiang; Veronique Kiak-Mien Tan; Benita Kiat-Tee Tan; Joanne Ngeow
Journal:  Hered Cancer Clin Pract       Date:  2020-10-23       Impact factor: 2.857

5.  Walking in the shoes of patients, not just in their genes: a patient-centered approach to genomic medicine.

Authors:  Neeraj K Arora; Bradford W Hesse; Steven B Clauser
Journal:  Patient       Date:  2015-06       Impact factor: 3.883

Review 6.  Decision making for breast cancer prevention among women at elevated risk.

Authors:  Tasleem J Padamsee; Celia E Wills; Lisa D Yee; Electra D Paskett
Journal:  Breast Cancer Res       Date:  2017-03-24       Impact factor: 6.466

7.  Effect of a Patient Decision Aid on Lung Cancer Screening Decision-Making by Persons Who Smoke: A Randomized Clinical Trial.

Authors:  Robert J Volk; Lisa M Lowenstein; Viola B Leal; Kamisha H Escoto; Scott B Cantor; Reginald F Munden; Vance A Rabius; Linda Bailey; Paul M Cinciripini; Heather Lin; Ashley J Housten; Pamela Graef Luckett; Angelina Esparza; Myrna C Godoy; Therese B Bevers
Journal:  JAMA Netw Open       Date:  2020-01-03

8.  Stress, anxiety, and health-related quality of life in BRCA1/2-positive women with and without cancer: A comparison of four US female samples.

Authors:  Kate E Dibble; Laura K M Donorfio; Preston A Britner; Keith M Bellizzi
Journal:  Gynecol Oncol Rep       Date:  2022-06-20

9.  Risk-reducing mastectomy decisions among women with mutations in high- and moderate- penetrance breast cancer susceptibility genes.

Authors:  Jacob G Comeaux; Julie O Culver; John E Lee; Danielle Dondanville; Heather L McArthur; Emily Quinn; Nicholas Gorman; Charité Ricker; Ming Li; Caryn Lerman
Journal:  Mol Genet Genomic Med       Date:  2022-08-25       Impact factor: 2.473

10.  The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing.

Authors:  Louisa L Lo; Ian M Collins; Mathias Bressel; Phyllis Butow; Jon Emery; Louise Keogh; Prue Weideman; Emma Steel; John L Hopper; Alison H Trainer; Gregory B Mann; Adrian Bickerstaffe; Antonis C Antoniou; Jack Cuzick; Kelly-Anne Phillips
Journal:  JMIR Form Res       Date:  2018-11-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.